TY  - JOUR
AU  - Llorenç, Victor
AU  - Cordero-Coma, Miguel
AU  - Blanco-Esteban, Ana
AU  - Heras-Mulero, Henar
AU  - Losada-Castillo, Maria-Jose
AU  - Jovani-Casano, Vega
AU  - Valls-Pascual, Elia
AU  - Jodar-Marquez, Margarita
AU  - García-Aparicio, Angel
AU  - Fonollosa, Alejandro
AU  - Gonzalez-Guijarro, Juan Jacobo
AU  - Rodriguez-Melian, Luis
AU  - Fernandez-Prada, Manuel
AU  - Jerez-Fidalgo, Maria
AU  - Hernandez-Garfella, Marisa
AU  - Esquinas, Cristina
AU  - Sainz-de-la-Maza, Maite
AU  - Adán, Alfredo
AU  - Biotherapies in Uveitis (BioÚvea) Study Group
PY  - 2019
DO  - 10.1016/j.ophtha.2019.11.024
UR  - http://hdl.handle.net/10668/14966
T2  - Ophthalmology
AB  - To study the drug retention rate (DRR), causes, and predictors of discontinuation of adalimumab (ADA) in a real-world uveitis setting. Multicentric, nationwide, registry-based, ambispective, observational study. Patients treated with ADA for...
LA  - en
PB  - Elsevier
KW  - Adalimumab
KW  - Anti-Inflammatory Agents
KW  - Biological Therapy
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Adult
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Proportional Hazards Models
KW  - Registries
KW  - Retrospective Studies
KW  - Spain
KW  - Uveitis
KW  - Withholding Treatment
KW  - Young Adult
TI  - Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.
TY  - research article
VL  - 127
ER  -